başkent üniversitesi tıp fakültesi çocuk sağlığı ve hastalıkları ...

94. Yorgin PD, Belson A, Sanchez J, Al Uzri AY, Sarwal M, Bloch DA, Oehlert J, Salvatierra
O, Alexander SR. Unexpectedly high prevalence of post-transplant anemia in pediatric and
young adult renal transplant recipients. Am J Kidney Dis 40: 1306-1318, 2002.
95. Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B,
Kliem V, Legendre C, Morais Sarmento AL, Vincenti F. Prevalence and management of
anemia in renal transplant recipients: a European survey. Am J Transplant 3: 835-845, 2003.
96. Embleton ND, O'Sullivan JJ, Hamilton JR, Dark JH, Summerfield GP. High prevalence of
anemia after cardiac transplantation in children. Transplantation 64: 1590–1594, 1997.
97. Misra S, Moore TB, Ament ME, Vargas JH, Busutill RW, McDiarmid SV. Profile of
anemia in children after liver transplantation. Transplantation 70: 1459–1463, 2000.
98. Guitard J, Ribes D, Kamar N, Muscari F, Lavayssière L, Suc B, Esposito L, Perron JM,
Rostaing L. Predictive factors for anemia within the first year after orthotopic liver
transplantation. Transplant Proc 38: 2342–2345, 2006.
99. Ndimbie OK, Frezza E, Jordan JA, Koch W, van Thiel DH. Parvovirus B19 in anemic liver
transplant recipients. Clin Diagn Lab Immonol 3: 756–760, 1996.
100. European FK506 Multicentre liver study group. Randomised trial comparing tacrolimus
(FK506) and cyclosporine in prevention of liver allograft rejection. Lancet 344: 423-428, 1994.
101. The US multicenter FK506 liver study group. A comparison of Tacrolimus (FK506) and
Cyclosporine for immunosuppression in liver transplantation. N Eng J Med 331: 1110–1115,
1994.
102. European mycophenolate mofetil cooperative study group. Placebo-controlled study of
mycophenolate mofetil combined with Cyclosporine and corticosteroids for prevention of
acute rejection. Lancet 345: 1321-1325, 1995.
103. Rerolle JP, Akposso K, Lerolle N, Mougenot B, Ponnelle T, Rondeau E, Sraer JD.
Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver
transplantation. Clin Transplant 14: 262-265, 2000.
104. Mach-Pascual S, Samii K, Beris P. Microangiopathic hemolytic anemia complicating
FK506 (Tacrolimus) therapy. Am J Hematol 52: 310-312, 1996.
105. Oteo J, Alonso-Pulpon L, Diez JL, Camacho C, Exposito C, Gonzalez A, Serrano-Fiz S.
Microangiopathic hemolytic anemia secondary to cyclosporine therapy in a heart and lung
transplant recipient. J Heart Lung Transplant 15: 322-324, 1996.
106. Misra S, Moore TB, Ament ME, Bussutil RW, McDiarmid SV. Red cell aplasia in
children in tacrolimus after liver transplantation. Transplantation 65: 575-577, 1998.
107. Stock PG, Steiner ME, Freese D, Sharp H, Ascher NL. Hepatitis associated aplastic
anemia after liver transplantation. Transplantation 43: 595–597, 1987.